Organization · Venture Capital
Kobold Capital
Kobold Capital is an Australian investment firm specializing in life sciences and emerging medical technologies. The firm targets high-value opportunities in both public and private life sciences companies.
Overview
What Kobold Capital does
What Kobold Capital is
Kobold Capital is an Australian investment firm specializing in life sciences and emerging medical technologies. The firm targets high-value opportunities in both public and private life sciences companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Kobold Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kobold Capital as a funder
Investment thesis
Kobold Capital invests selectively across life sciences to find high-growth companies or those approaching meaningful value inflection points, leveraging scientific, IP, and commercial diligence.
Focus narrative
Kobold Capital invests in life sciences, greentech, deep tech, and artificial intelligence. The firm targets investments with the potential for exponential growth or those nearing significant value inflection points. They engage in both private and public investments, including pre-IPO and early-stage seed rounds, focusing on high-impact opportunities.
Value beyond capital
Kobold Capital adds value to its portfolio companies through active involvement, leveraging its team's extensive experience in scientific, IP, and capital markets. The firm focuses on companies with differentiated science or IP, credible management, and defined milestones to facilitate rapid value creation.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Pre-IPO
- Regions
- Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Kobold Capital has a track record of investing in early-stage life sciences and technology companies. Notable portfolio companies include Avexa Ltd (ASX:AVX), Opyl Ltd (ASX:OPL), Admedus Ltd (ASX:AHZ), and CANN Group (ASX:CAN).
Common questions
What to know about Kobold Capital
Upseed classifies Kobold Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.